Read transcripts of debates in both Houses
Produced by Commons Library, Lords Library and Parliamentary Office Science and Technology
Search for Members by name, postcode, constituency and party
Learn about their experience, knowledge and interests
Celebrating people who have made Parliament a positive, inclusive working environment
Four staff networks for people to discuss and consider issues.
Contact your MP or a Member of the House of Lords about an issue that matters to you
Find and register for Parliament's free events and training sessions
Take a tour of Parliament and enjoy a delicious afternoon tea by the River Thames
See some of the sights you’ll encounter on a tour of Parliament
Book a school visit, classroom workshop or teacher-training session
Access videos, worksheets, lesson plans and games
Science and Technology Committee (Commons)
Oral evidence concluded. Report in preparation.
The Science and Technology Committee is undertaking an inquiry into regenerative medicine. Regenerative medicine (or advanced therapies) involves replacing or regenerating cells, tissues or organs in order to restore or establish normal function in people with chronic illnesses. It has been used, for example, in bone marrow transplants and offers the prospect of more effective repairs for faulty hearts, skin burns and worn-out joints. Regenerative medicine includes cell therapy, gene therapy, tissue engineering and other methods.
Evidence given by Dr Nick Crabb, Programme Director, Scientific Affairs, National Institute for Health and Care Excellence, Dr Jonathan Fielden, Director of Specialised Commissioning and Deputy National Medical Director, NHS England, and Dr James Palmer, Clinical Director of Specialised Commissioning, NHS England; Professor Amit Nathwani, Professor of Haematology, Royal Free Hospital, Professor Giovanna Lombardi, Professor of Human Transplant Immunology, King’s College London, and Dr Anthony Mathur, Professor of Cardiology, Queen Mary’s School of Medicine and Dentistry; Lord Prior of Brampton, Parliamentary Under-Secretary of State for Health, Department of Health
There are currently no public meetings scheduled.
Science and Technology Committee examine issues including the adoption of regenerative medicine therapies looking at NHS infrastructure